Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 715 entries
Sorted by: Best Match Show Resources per page
The behavioral dimensions of trading: Proximal and distal influences on performance

instructional innovation

Gould S, Valenzuela A.
GSID: 3QlSbJ7yXbYJ
S Gould, A Valenzuela, L Kachersky… - ACR North American …, 2010 - acrwebsite.org

Behavioral finance theory suggests that individual investments decisions will, to a certain extent, be affected by characteristics of one's personal psychology and what are said to be …

Cite
Gould, S., Valenzuela, A., Kachersky, L., & Holowczak, R. (2010). The behavioral dimensions of trading: Proximal and distal influences on performance. ACR North American Advances.
Gould, Stephen, et al. "The behavioral dimensions of trading: Proximal and distal influences on performance." ACR North American Advances (2010).
Copy Download .nbib Format: MLA
Cardiac nursing.

Nursing

Gould D.
PMID: 2761825
Nursing (Lond). 1989 Apr;3(36):17-8.

No abstract available.

Cite
Gould D. Cardiac nursing. Nursing (Lond). 1989;3(36):17-8
Gould, D. (1989). Cardiac nursing. Nursing, 3(36), 17-8.
Gould, D. "Cardiac nursing." Nursing vol. 3,36 (1989): 17-8.
Gould D. Cardiac nursing. Nursing (Lond). 1989 Apr;3(36):17-8. PMID: 2761825.
Copy Download .nbib Format: NLM
Professional probe. 2. That worrying habit. Interview by Catharine Sadler.

Nursing mirror

Gould D.
PMID: 3849765
Nurs Mirror. 1985 Aug 21;161(8):25-7.

No abstract available.

Cite
Gould D. Professional probe. 2. That worrying habit. Interview by Catharine Sadler. Nurs Mirror. 1985;161(8):25-7
Gould, D. (1985). Professional probe. 2. That worrying habit. Interview by Catharine Sadler. Nursing mirror, 161(8), 25-7.
Gould, D. "Professional probe. 2. That worrying habit. Interview by Catharine Sadler." Nursing mirror vol. 161,8 (1985): 25-7.
Gould D. Professional probe. 2. That worrying habit. Interview by Catharine Sadler. Nurs Mirror. 1985 Aug 21;161(8):25-7. PMID: 3849765.
Copy Download .nbib Format: NLM
A case of Gangrene of the Lung following Necrosis of the Temporal Bone, the result of Scarlet Fever. Treatment by Drainage. Recovery.

Medico-chirurgical transactions

Cayley W, Gould AP.
PMID: 20896633
Med Chir Trans. 1884;67:209-216.1. doi: 10.1177/095952878406700117.

No abstract available.

Cite
Cayley W, Gould AP. A case of Gangrene of the Lung following Necrosis of the Temporal Bone, the result of Scarlet Fever. Treatment by Drainage. Recovery. Med Chir Trans. 1884;67:209-216.1doi: 10.1177/095952878406700117.
Cayley, W., & Gould, A. P. (1884). A case of Gangrene of the Lung following Necrosis of the Temporal Bone, the result of Scarlet Fever. Treatment by Drainage. Recovery. Medico-chirurgical transactions, 67209-216.1. https://doi.org/10.1177/095952878406700117
Cayley, W, and Gould, A P. "A case of Gangrene of the Lung following Necrosis of the Temporal Bone, the result of Scarlet Fever. Treatment by Drainage. Recovery." Medico-chirurgical transactions vol. 67 (1884): 209-216.1. doi: https://doi.org/10.1177/095952878406700117
Cayley W, Gould AP. A case of Gangrene of the Lung following Necrosis of the Temporal Bone, the result of Scarlet Fever. Treatment by Drainage. Recovery. Med Chir Trans. 1884;67:209-216.1. doi: 10.1177/095952878406700117. PMID: 20896633; PMCID: PMC2121390.
Copy Download .nbib Format: NLM
Your tributes.

Nursing standard (Royal College of Nursing (Great Britain) : 1987)

Holleran C, Gould A, Darley M, Clark M, Quinn DS, Stallknecht K, Greene J, Eherhardie C, Sheet M, Hockey L, Friend DP.
PMID: 27657973
Nurs Stand. 1993 Mar 17;7(26):45. doi: 10.7748/ns.7.26.45.s57.

• Dr Mo-Im Kim, President of the International Council of Nurses, has asked me to convey her deepest sympathy and that of the ICN Board of Directors and staff on the death of Robert Tiffany.

Cite
Holleran C, Gould A, Darley M, et al. Your tributes. Nurs Stand. 1993;7(26):45doi: 10.7748/ns.7.26.45.s57.
Holleran, C., Gould, A., Darley, M., Clark, M., Quinn, D. S., Stallknecht, K., Greene, J., Eherhardie, C., Sheet, M., Hockey, L., & Friend, D. P. (1993). Your tributes. Nursing standard (Royal College of Nursing (Great Britain) : 1987), 7(26), 45. https://doi.org/10.7748/ns.7.26.45.s57
Holleran, Constance, et al. "Your tributes." Nursing standard (Royal College of Nursing (Great Britain) : 1987) vol. 7,26 (1993): 45. doi: https://doi.org/10.7748/ns.7.26.45.s57
Holleran C, Gould A, Darley M, Clark M, Quinn DS, Stallknecht K, Greene J, Eherhardie C, Sheet M, Hockey L, Friend DP. Your tributes. Nurs Stand. 1993 Mar 17;7(26):45. doi: 10.7748/ns.7.26.45.s57. PMID: 27657973.
Copy Download .nbib Format: NLM
Implementation of pharmacokinetic and pharmacodynamic strategies in early research phases of drug discovery and development at Novartis Institute of Biomedical Research.

Frontiers in pharmacology

Tuntland T, Ethell B, Kosaka T, Blasco F, Zang RX, Jain M, Gould T, Hoffmaster K.
PMID: 25120485
Front Pharmacol. 2014 Jul 28;5:174. doi: 10.3389/fphar.2014.00174. eCollection 2014.

Characterizing the relationship between the pharmacokinetics (PK, concentration vs. time) and pharmacodynamics (PD, effect vs. time) is an important tool in the discovery and development of new drugs in the pharmaceutical industry. The purpose of this publication is to...

Cite
Tuntland T, Ethell B, Kosaka T, et al. Implementation of pharmacokinetic and pharmacodynamic strategies in early research phases of drug discovery and development at Novartis Institute of Biomedical Research. Front Pharmacol. 2014;5:174doi: 10.3389/fphar.2014.00174.
Tuntland, T., Ethell, B., Kosaka, T., Blasco, F., Zang, R. X., Jain, M., Gould, T., & Hoffmaster, K. (2014). Implementation of pharmacokinetic and pharmacodynamic strategies in early research phases of drug discovery and development at Novartis Institute of Biomedical Research. Frontiers in pharmacology, 5174. https://doi.org/10.3389/fphar.2014.00174
Tuntland, Tove, et al. "Implementation of pharmacokinetic and pharmacodynamic strategies in early research phases of drug discovery and development at Novartis Institute of Biomedical Research." Frontiers in pharmacology vol. 5 (2014): 174. doi: https://doi.org/10.3389/fphar.2014.00174
Tuntland T, Ethell B, Kosaka T, Blasco F, Zang RX, Jain M, Gould T, Hoffmaster K. Implementation of pharmacokinetic and pharmacodynamic strategies in early research phases of drug discovery and development at Novartis Institute of Biomedical Research. Front Pharmacol. 2014 Jul 28;5:174. doi: 10.3389/fphar.2014.00174. eCollection 2014. PMID: 25120485; PMCID: PMC4112793.
Copy Download .nbib Format: NLM
Nephrocalcinosis in a young male with anorexia nervosa.

CEN case reports

Chadi N, Carter S, Loung RPY, Gould M, Hick K.
PMID: 28669007
CEN Case Rep. 2017 Nov;6(2):164-168. doi: 10.1007/s13730-017-0267-0. Epub 2017 Jul 01.

Nephrocalcinosis (NC) has been described as a long-term complication of anorexia nervosa (AN). This is the first report of this complication in an adolescent male patient. We describe the case of a 12-year-old male with AN who presented with...

Cite
Chadi N, Carter S, Loung RPY, et al. Nephrocalcinosis in a young male with anorexia nervosa. CEN Case Rep. 2017;6(2):164-168doi: 10.1007/s13730-017-0267-0.
Chadi, N., Carter, S., Loung, R. P. Y., Gould, M., & Hick, K. (2017). Nephrocalcinosis in a young male with anorexia nervosa. CEN case reports, 6(2), 164-168. https://doi.org/10.1007/s13730-017-0267-0
Chadi, Nicholas, et al. "Nephrocalcinosis in a young male with anorexia nervosa." CEN case reports vol. 6,2 (2017): 164-168. doi: https://doi.org/10.1007/s13730-017-0267-0
Chadi N, Carter S, Loung RPY, Gould M, Hick K. Nephrocalcinosis in a young male with anorexia nervosa. CEN Case Rep. 2017 Nov;6(2):164-168. doi: 10.1007/s13730-017-0267-0. Epub 2017 Jul 01. PMID: 28669007; PMCID: PMC5694405.
Copy Download .nbib Format: NLM
Safety, Pharmacokinetics, and Pharmacodynamic Effects of a Selective TGR5 Agonist, SB-756050, in Type 2 Diabetes.

Clinical pharmacology in drug development

Hodge RJ, Lin J, Vasist Johnson LS, Gould EP, Bowers GD, Nunez DJ.
PMID: 27121782
Clin Pharmacol Drug Dev. 2013 Jul;2(3):213-22. doi: 10.1002/cpdd.34. Epub 2013 May 14.

TGR5 is a bile acid receptor and a potential target for the treatment of type 2 diabetes (T2D). We report here the safety, pharmacokinetics, and pharmacodynamic effects of a selective TGR5 agonist, SB-756050, in patients with T2D. Fifty-one subjects...

Cite
Hodge RJ, Lin J, Vasist Johnson LS, et al. Safety, Pharmacokinetics, and Pharmacodynamic Effects of a Selective TGR5 Agonist, SB-756050, in Type 2 Diabetes. Clin Pharmacol Drug Dev. 2013;2(3):213-22doi: 10.1002/cpdd.34.
Hodge, R. J., Lin, J., Vasist Johnson, L. S., Gould, E. P., Bowers, G. D., Nunez, D. J. (2013). Safety, Pharmacokinetics, and Pharmacodynamic Effects of a Selective TGR5 Agonist, SB-756050, in Type 2 Diabetes. Clinical pharmacology in drug development, 2(3), 213-22. https://doi.org/10.1002/cpdd.34
Hodge, Rebecca J, et al. "Safety, Pharmacokinetics, and Pharmacodynamic Effects of a Selective TGR5 Agonist, SB-756050, in Type 2 Diabetes." Clinical pharmacology in drug development vol. 2,3 (2013): 213-22. doi: https://doi.org/10.1002/cpdd.34
Hodge RJ, Lin J, Vasist Johnson LS, Gould EP, Bowers GD, Nunez DJ. Safety, Pharmacokinetics, and Pharmacodynamic Effects of a Selective TGR5 Agonist, SB-756050, in Type 2 Diabetes. Clin Pharmacol Drug Dev. 2013 Jul;2(3):213-22. doi: 10.1002/cpdd.34. Epub 2013 May 14. PMID: 27121782.
Copy Download .nbib Format: NLM
Synthesis and crystal structure of a new hexagonal perovskite 7H-Ba7Li1.75Mn3.5O15.75 with Mn(4+)/Mn(5+) charge distribution.

Dalton transactions (Cambridge, England : 2003)

Tarakina NV, Tyutyunnik AP, Bazuev GV, Vasiliev AD, Vasilev AD, Gould C, Nikolaenko IV, Berger IF.
PMID: 26442571
Dalton Trans. 2015 Nov 14;44(42):18527-35. doi: 10.1039/c5dt01528f. Epub 2015 Oct 07.

Ba7Li1.75Mn3.5O15.75 is a new hexagonal perovskite whose crystal structure has elements typical for the layered hexagonal perovskites and quasi-one-dimensional oxides, hence representing a new polytype. It has been synthesized via a solid-state microwave route. The crystal structure was solved...

Cite
Tarakina NV, Tyutyunnik AP, Bazuev GV, et al. Synthesis and crystal structure of a new hexagonal perovskite 7H-Ba7Li1.75Mn3.5O15.75 with Mn(4+)/Mn(5+) charge distribution. Dalton Trans. 2015;44(42):18527-35doi: 10.1039/c5dt01528f.
Tarakina, N. V., Tyutyunnik, A. P., Bazuev, G. V., Vasiliev, A. D., Vasilev, A. D., Gould, C., Nikolaenko, I. V., & Berger, I. F. (2015). Synthesis and crystal structure of a new hexagonal perovskite 7H-Ba7Li1.75Mn3.5O15.75 with Mn(4+)/Mn(5+) charge distribution. Dalton transactions (Cambridge, England : 2003), 44(42), 18527-35. https://doi.org/10.1039/c5dt01528f
Tarakina, N V, et al. "Synthesis and crystal structure of a new hexagonal perovskite 7H-Ba7Li1.75Mn3.5O15.75 with Mn(4+)/Mn(5+) charge distribution." Dalton transactions (Cambridge, England : 2003) vol. 44,42 (2015): 18527-35. doi: https://doi.org/10.1039/c5dt01528f
Tarakina NV, Tyutyunnik AP, Bazuev GV, Vasiliev AD, Vasilev AD, Gould C, Nikolaenko IV, Berger IF. Synthesis and crystal structure of a new hexagonal perovskite 7H-Ba7Li1.75Mn3.5O15.75 with Mn(4+)/Mn(5+) charge distribution. Dalton Trans. 2015 Nov 14;44(42):18527-35. doi: 10.1039/c5dt01528f. Epub 2015 Oct 07. PMID: 26442571.
Copy Download .nbib Format: NLM
Discovery and Evaluation of Clinical Candidate IDH305, a Brain Penetrant Mutant IDH1 Inhibitor.

ACS medicinal chemistry letters

Cho YS, Levell JR, Liu G, Caferro T, Sutton J, Shafer CM, Costales A, Manning JR, Zhao Q, Sendzik M, Shultz M, Chenail G, Dooley J, Villalba B, Farsidjani A, Chen J, Kulathila R, Xie X, Dodd S, Gould T, Liang G, Heimbach T, Slocum K, Firestone B, Pu M, Pagliarini R, Growney JD.
PMID: 29057061
ACS Med Chem Lett. 2017 Sep 18;8(10):1116-1121. doi: 10.1021/acsmedchemlett.7b00342. eCollection 2017 Oct 12.

Inhibition of mutant IDH1 is being evaluated clinically as a promising treatment option for various cancers with hotspot mutation at Arg

Cite
Cho YS, Levell JR, Liu G, et al. Discovery and Evaluation of Clinical Candidate IDH305, a Brain Penetrant Mutant IDH1 Inhibitor. ACS Med Chem Lett. 2017;8(10):1116-1121doi: 10.1021/acsmedchemlett.7b00342.
Cho, Y. S., Levell, J. R., Liu, G., Caferro, T., Sutton, J., Shafer, C. M., Costales, A., Manning, J. R., Zhao, Q., Sendzik, M., Shultz, M., Chenail, G., Dooley, J., Villalba, B., Farsidjani, A., Chen, J., Kulathila, R., Xie, X., Dodd, S., Gould, T., Liang, G., Heimbach, T., Slocum, K., Firestone, B., Pu, M., Pagliarini, R., & Growney, J. D. (2017). Discovery and Evaluation of Clinical Candidate IDH305, a Brain Penetrant Mutant IDH1 Inhibitor. ACS medicinal chemistry letters, 8(10), 1116-1121. https://doi.org/10.1021/acsmedchemlett.7b00342
Cho, Young Shin, et al. "Discovery and Evaluation of Clinical Candidate IDH305, a Brain Penetrant Mutant IDH1 Inhibitor." ACS medicinal chemistry letters vol. 8,10 (2017): 1116-1121. doi: https://doi.org/10.1021/acsmedchemlett.7b00342
Cho YS, Levell JR, Liu G, Caferro T, Sutton J, Shafer CM, Costales A, Manning JR, Zhao Q, Sendzik M, Shultz M, Chenail G, Dooley J, Villalba B, Farsidjani A, Chen J, Kulathila R, Xie X, Dodd S, Gould T, Liang G, Heimbach T, Slocum K, Firestone B, Pu M, Pagliarini R, Growney JD. Discovery and Evaluation of Clinical Candidate IDH305, a Brain Penetrant Mutant IDH1 Inhibitor. ACS Med Chem Lett. 2017 Sep 18;8(10):1116-1121. doi: 10.1021/acsmedchemlett.7b00342. eCollection 2017 Oct 12. PMID: 29057061; PMCID: PMC5641959.
Copy Download .nbib Format: NLM
A universal preconditioner for simulating condensed phase materials.

The Journal of chemical physics

Packwood D, Kermode J, Mones L, Bernstein N, Woolley J, Gould N, Ortner C, Csányi G.
PMID: 27131533
J Chem Phys. 2016 Apr 28;144(16):164109. doi: 10.1063/1.4947024.

We introduce a universal sparse preconditioner that accelerates geometry optimisation and saddle point search tasks that are common in the atomic scale simulation of materials. Our preconditioner is based on the neighbourhood structure and we demonstrate the gain in...

Cite
Packwood D, Kermode J, Mones L, et al. A universal preconditioner for simulating condensed phase materials. J Chem Phys. 2016;144(16):164109doi: 10.1063/1.4947024.
Packwood, D., Kermode, J., Mones, L., Bernstein, N., Woolley, J., Gould, N., Ortner, C., & Csányi, G. (2016). A universal preconditioner for simulating condensed phase materials. The Journal of chemical physics, 144(16), 164109. https://doi.org/10.1063/1.4947024
Packwood, David, et al. "A universal preconditioner for simulating condensed phase materials." The Journal of chemical physics vol. 144,16 (2016): 164109. doi: https://doi.org/10.1063/1.4947024
Packwood D, Kermode J, Mones L, Bernstein N, Woolley J, Gould N, Ortner C, Csányi G. A universal preconditioner for simulating condensed phase materials. J Chem Phys. 2016 Apr 28;144(16):164109. doi: 10.1063/1.4947024. PMID: 27131533.
Copy Download .nbib Format: NLM
Opinions of Hospital Pharmacists in Canada Regarding Marijuana for Medical Purposes.

The Canadian journal of hospital pharmacy

Mitchell F, Gould O, LeBlanc M, Manuel L.
PMID: 27168633
Can J Hosp Pharm. 2016 Mar-Apr;69(2):122-30. doi: 10.4212/cjhp.v69i2.1539. Epub 2016 Apr 29.

BACKGROUND: Canada's most recent Marihuana for Medical Purposes Regulations have changed the way in which patients access marijuana. Furthermore, if authorized by the person in charge of the hospital, a pharmacist practising in a hospital may now place orders...

Cite
Mitchell F, Gould O, LeBlanc M, et al. Opinions of Hospital Pharmacists in Canada Regarding Marijuana for Medical Purposes. Can J Hosp Pharm. 2016;69(2):122-30doi: 10.4212/cjhp.v69i2.1539.
Mitchell, F., Gould, O., LeBlanc, M., & Manuel, L. (2016). Opinions of Hospital Pharmacists in Canada Regarding Marijuana for Medical Purposes. The Canadian journal of hospital pharmacy, 69(2), 122-30. https://doi.org/10.4212/cjhp.v69i2.1539
Mitchell, Fiona, et al. "Opinions of Hospital Pharmacists in Canada Regarding Marijuana for Medical Purposes." The Canadian journal of hospital pharmacy vol. 69,2 (2016): 122-30. doi: https://doi.org/10.4212/cjhp.v69i2.1539
Mitchell F, Gould O, LeBlanc M, Manuel L. Opinions of Hospital Pharmacists in Canada Regarding Marijuana for Medical Purposes. Can J Hosp Pharm. 2016 Mar-Apr;69(2):122-30. doi: 10.4212/cjhp.v69i2.1539. Epub 2016 Apr 29. PMID: 27168633; PMCID: PMC4853179.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 715 entries